[at noodls] – NeoStem CEO’s Letter to Shareholders Mar 19 2013 Dear NeoStem Shareholders, Regenerative medicine is the catalyst to radically change the practice of medicine from that of chronic treatment to that of … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboardSee who Neostem is hiring next, click here to […]
[at noodls] – Mar 7 2013 New York, March 7, 2013 – NeoStem, Inc. (NYSE MKT:NBS) (NeoStem or the Company), a leader in the fast growing cell therapy market, today announced that, on March 6, 2013, … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboardSee who Neostem is hiring next, click […]
[at noodls] – Feb 11 2013 New York, February 11, 2013 — NeoStem, Inc. (NYSE MKT:NBS) (NeoStem or the Company), an emerging leader in the fast growing cell therapy market, today announced that … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboardSee who Neostem is hiring next, click here to view […]
[at noodls] – NeoStem’s Vice President of Clinical Development and Regulatory Affairs to Present at Two Venues This Week Feb 4 2013 New York, Feb. 4, 2013 — NeoStem, Inc. (NYSE MKT:NBS) (NeoStem or the … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboardSee who Neostem is hiring next, click here […]
[at noodls] – NeoStem’s Vice President of Clinical Development and Regulatory Affairs to Present at Two Venues This Week Feb 4 2013 New York, Feb. 4, 2013 — NeoStem, Inc. (NYSE MKT:NBS) (NeoStem or the … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboardSee who Neostem is hiring next, click here […]
[at noodls] – Jan 22 2013 NeoStem, Inc. (NYSE MKT:NBS) today announced the expansion of intellectual property protection around its lead product candidate, AMR-001, with the grant of U.S. patent number 8,343,485 entitled … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboardSee who Neostem is hiring next, click here to view […]
[at noodls] – Jan 9 2013 New York, Jan. 9, 2013 — NeoStem, Inc. (NYSE MKT:NBS), an emerging leader in the fast growing cell therapy market, announced today that multiple abstracts presented December 8-11 at the 2012 … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboardSee who Neostem is hiring next, […]
[at noodls] – NeoStem’s Subsidiary, Progenitor Cell Therapy, and Hackensack University Medical Center Enter Into a Cell Processing and Storage Services Agreement Jan 7 2013 ALLENDALE, N.J. and HACKENSACK, N.J., Jan. … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboardSee who Neostem is hiring next, click here to view […]
[at noodls] – Jan 2 2013 NEW YORK, Jan. 2, 2013 (GLOBE NEWSWIRE) — NeoStem, Inc. (NYSE MKT:NBS) (NeoStem or the Company), an emerging leader in the fast growing cell therapy market, today announced … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboardSee who Neostem is hiring next, click here to […]
[at noodls] – Nov 26 2012 New York, Nov. 26, 2012 — NeoStem, Inc. (NYSE MKT:NBS) (NeoStem or the Company), an emerging leader in the fast growing cell therapy industry, today announced that … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboard […]
